Post-market follow-up of ChitoCare® Medical for scars, post-dermatological care, dermatitis, and acne

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational post-marketing follow-up of ChitoCare® Medical gel and spray to confirm safety and effectiveness in real-world use for scars, post-dermatosurgical skin, dermatitis, and acne under EU Regulation 2017/745. Participants use the marketed products per their labeled indications while clinicians record healing outcomes and any adverse events during routine dermatology visits. Inclusion follows the product indications and the only exclusion listed is allergy to an ingredient. The investigation is conducted at dermatology departments in Prague and collects real-world safety and effectiveness data rather than performing randomized comparisons.

Why it matters

Who can join: the full rules

The inclusion criteria are fully according to indications:

* Gel - scars, conditions after dermatosurgical procedures, dermatitis, acne
* Spray - conditions after dermatosurgical procedures, dermatitis, acne

The criteria for exclusion are fully according to contraindications:

* Allergy to any of the ingredients of the product

Where it's running

• Dermatovenerology department, FN Motol
  Prague, Czechia Recruiting
• Dermatology of Prof. Hercogova
  Prague, Czechia Recruiting

Study contacts

• Study coordinator: Craig Fraser, PhD
• Email: craig@chitocare.com
• Phone: +354 846 1912

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Treatment for various skin conditions using AVAVA technology

  This study is testing a new device called AVAVA to see if it can help improve skin problems like acne, scars, and wrinkles.

  Recruiting AVAVA, Inc. · Waltham, Massachusetts · NCT06868615

• Adapalene/Clindamycin Gel in Vietnamese Acne Patients

  This study tests how safe and tolerable and how well Klenzit-C works when used in routine care by Vietnamese patients aged 12 and up with mild to moderate acne.

  Recruiting at 2 sites Phase 4 Ir Innovate Research Private Limited · Hanoi and 2 other locations · NCT07918001

• Skincare regimen for mild to moderate acne in people with sensitive skin

  A 4-week test will check if a skincare regimen helps with mild to moderate acne in adults with sensitive skin.

  Recruiting USMARI Research & Innovation Centre · Petaling Jaya, Selangor · NCT07749469

• Camoteskimab in adults with moderate-to-severe atopic dermatitis

  This trial tests different doses of camoteskimab versus placebo to see if it helps adults with moderate-to-severe atopic dermatitis who have not fully responded to standard treatments.

  Recruiting at 31 sites Phase 2 Apollo Therapeutics Ltd · Birmingham, Alabama and 84 other locations · NCT07599813

• Single subcutaneous dose of SHR-1894 in healthy adults

  This trial will test a single under-the-skin (subcutaneous) dose of SHR-1894 in healthy adults to see if it is safe and how the body processes it.

  Recruiting Phase 1 Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Chengdu, Sichuan · NCT07414602

• Engineered Lactobacillus reuteri cream with zinc sulfate–tannic acid MPN coating for acne

  This trial will test whether a topical cream containing engineered Lactobacillus reuteri with a zinc sulfate–tannic acid coating can reduce inflammatory acne in adults aged 18–33.

  Recruiting Phase 2 Shenzhen People's Hospital · Shenzhen, Guangdong · NCT07366229

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.